KRISTINE ABIGAEL MALCOMSON: Open Payments
NPI 1609457027 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,004 in 13 payments from 8 companies in 2025. Trend: 2023 $371 · 2024 $212 · 2025 $1,004
Food & beverage: $1,004
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $267 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| Alkermes, Inc. | 1 | $122 |
| ACADIA Pharmaceuticals Inc | 2 | $120 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $117 |
| Otsuka America Pharmaceutical, Inc. | 1 | $104 |
| PFIZER INC. | 1 | $24 |
Products named: VRAYLAR, Auvelity, COBENFY, LYBALVI, NUPLAZID, CAPLYTA, REXULTI, PREVNAR 20.
Industry payments across AZ — which companies pay providers there.
